5-Amino-1MQ 30mg — Vial Spec, Reconstitution Math & COA

Overview of 5-Amino-1MQ 30mg Vial Specifications

The 30mg fill quantity of 5-Amino-1MQ (5-amino-1-methylquinolinium) represents a high-capacity unit designed for laboratories conducting high-density cellular screens or longitudinal rodent metabolic studies. Each vial contains 30 milligrams of active small-molecule quinolinium salt presented as a solid lyophilized cake. This dry state maintains thermodynamic stability and prevents chemical degradation during transport and long-term storage.

In institutional research environments, selecting a 30mg vial minimizes batch-handling steps compared to lower-yield single-use vials. Laboratories can consult our complete catalog of research peptides to compare mass options based on assay design. While smaller mass units like the 5-Amino-1MQ 5mg vial suit initial feasibility trials, the 30mg configuration reduces vial turnover during multi-week preclinical protocols, standardizing solute concentration across large sample groups.

PX1 Research supplies 5-Amino-1MQ strictly for in vitro and laboratory research applications. It is not intended for human or veterinary administration. Every lot is processed in ISO 17025 certified laboratory environments to ensure absolute mass accuracy, zero cross-contamination, and strict low-endotoxin thresholds.

Biological Mechanism: NNMT Inhibition & NAD+ Regulation

5-Amino-1MQ functions as a selective, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM). By forming 1-methylnicotinamide (MNA), active NNMT effectively sequesters nicotinamide from the salvage pathway, preventing its conversion back into nicotinamide adenine dinucleotide (NAD+). Preclinical studies suggest that elevated NNMT activity correlates with decreased cellular NAD+ availability and compromised mitochondrial respiration.

By inhibiting NNMT, 5-Amino-1MQ prevents the irreversible methylation of nicotinamide, directly supporting the salvage pathway responsible for synthesizing intracellular NAD+. In vitro data indicate that elevated NAD+ concentrations enhance silent information regulator 1 (SIRT1) signaling and activate poly(ADP-ribose) polymerase (PARP) enzymatic cascades. Consequently, researchers utilize this compound to investigate downstream effects on cellular energy homeostasis, mitochondrial biogenesis, and mitochondrial electron transport chain performance.

Furthermore, animal study models targeting obesity and metabolic dysfunction have demonstrated that NNMT inhibition shifts adipocyte gene expression profiles. By preserving intracellular SAM and NAD+ pools, 5-Amino-1MQ is studied for raising NAD+ levels, improving mitochondrial output, and supporting fat-metabolism research. This mechanism provides a valuable model for exploring metabolic rate modulation without direct adrenergic receptor stimulation.

Reconstitution Math and Concentration Calculations

Accurate dilution of a 30mg lyophilized cake requires precise volumetric math to achieve targeted stock concentrations for laboratory pipette dispensing. Because 30 milligrams represents a substantial mass compared to standard microgram-scale peptides, solvent volume selection directly impacts solution viscosity, solubilization rate, and aliquot volumetric precision.

To calculate working stock concentration, researchers apply the standard mass-over-volume equation: Concentration (mg/mL) = Mass (mg) / Volume (mL). To simplify laboratory workflow preparation, utilize the following standardized dilution ratios for a 30mg fill:

1. Reconstitution with 1.0 mL Diluent: Yields a concentration of 30.0 mg/mL (30,000 µg/mL). This high-density stock is optimal for concentrated master mixes or storage in micro-aliquots where minimal diluent volume is required.

2. Reconstitution with 2.0 mL Diluent: Yields a concentration of 15.0 mg/mL (15,000 µg/mL). Recommended for general laboratory micro-pipetting, offering a balance between volumetric accuracy and moderate solution viscosity.

3. Reconstitution with 3.0 mL Diluent: Yields a concentration of 10.0 mg/mL (10,000 µg/mL). Ideal for low-concentration cell culture media dosing where larger liquid transfers reduce pipetting error margins.

Researchers calculating specific molar concentrations or requiring custom dilutions can utilize our interactive reconstitution calculator to adjust for target micromolar (µM) assay parameters.

Laboratory Reconstitution and Solubilization Protocol

Reconstituting 30mg of 5-Amino-1MQ requires careful handling to achieve complete dissolution without causing shearing forces or introducing biological contaminants. The lyophilized cake should be brought to room temperature prior to solvent introduction to prevent condensation accumulation inside the vial walls.

Using sterile technique inside a laminar flow hood, inject the selected volume of laboratory-grade diluent—typically Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS)—along the internal glass wall of the vial. Avoid directing the liquid stream directly onto the lyophilized powder mass. Allow the diluent to wet the solid matrix naturally over 30 to 60 seconds.

Gently swirl the vial in a circular motion until the solution is completely clear and free of particulate matter. Do not vortex vigorously, as aggressive agitation can introduce micro-bubbles and disrupt compound stability. Once fully dissolved, visually inspect the liquid against a dark background to verify complete solubilization prior to aliquot division.

Aliquot Management and Storage Conditions

Unreconstituted, lyophilized 5-Amino-1MQ 30mg vials should be stored in a dark, temperature-controlled environment at -20°C for short-to-medium term storage, or -80°C for long-term storage extending past 12 months. Controlled low temperatures prevent spontaneous hydrolytic degradation and maintain powder integrity.

Following reconstitution, liquid stock solutions must be handled with strict freeze-thaw mitigation protocols. Repeated freeze-thaw cycles cause phase-separation stress and concentration gradients that degrade small-molecule integrity. The 30mg total mass should be immediately subdivided into single-use micro-aliquots (e.g., 50 µL to 200 µL) in sterile, polypropylene microcentrifuge tubes.

Working aliquots stored at 2°C to 8°C should be utilized within 7 to 14 days, depending on the solvent system used. Freeze aliquots destined for future experimental blocks at -20°C or -80°C. Never return a thawed aliquot to freezer storage; discard any residual unused portion following assay completion to maintain research reproducibility.

Lot-Matched Analytical Quality Control: COA Verification

Every production lot of 5-Amino-1MQ manufactured for PX1 Research undergoes rigorous analytical verification before release. Quality assurance protocols confirm molecular identity, purity percentage, heavy metal content, and biological cleanliness to protect downstream assay integrity.

High-Performance Liquid Chromatography (HPLC) is conducted on every batch to confirm chemical purity, targeting a baseline threshold of ≥98.0%. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass and chemical identity of the 5-amino-1-methylquinolinium structure, ensuring the absence of unreacted precursors or synthesis side-products.

In addition to structural verification, quantitative bacterial endotoxin testing (LAL assay) confirms that endotoxin levels remain below strict institutional safety guidelines (<0.01 EU/mg). Researchers can directly download and review lot-specific Certificates of Analysis corresponding to their exact vial batch number through the PX1 compliance portal.

Comparing 30mg Vials to Alternative Unit Masses

Choosing between a 30mg fill size and lower unit masses depends on experimental scale, total reagent demand, and workflow logistics. While smaller sizes reduce single-session exposure risk, high-throughput applications benefit significantly from centralized bulk reconstitution.

For small pilot studies, single-plate cell assays, or technique validation, the 5-Amino-1MQ 5mg vial provides sufficient material without leaving large volumes of reconstituted stock in long-term storage. Conversely, continuous multi-week rodent research or high-density screen arrays typically consume 15mg to 60mg per experimental block.

Utilizing 30mg vials in high-volume research reduces total vial opening steps, limits variable meniscus loss across multiple smaller containers, and ensures uniform compound purity from a single analytical lot across an entire trial cohort.

Comparative Analysis: 5-Amino-1MQ & Metabolic Compounds

In preclinical metabolic research, 5-Amino-1MQ represents one of several molecular tools used to investigate energy expenditure, mitochondrial function, and cellular nutrient sensing. Understanding how its mechanism compares with adjacent research compounds assists in broad experimental design.

While 5-Amino-1MQ targets cytosolic NNMT to elevate intracellular NAD+ and optimize fat metabolism, mitochondrial-derived peptides like MOTS-c operate via AMPK activation pathways to regulate systemic insulin sensitivity and metabolic homeostasis in cell models. Similarly, cardiolipin-targeting compounds such as SS-31 focus on restoring inner mitochondrial membrane integrity and optimizing ATP production directly within electron transport complexes. Additionally, growth hormone secretagogues like Tesamorelin modulate lipolysis indirectly via neuroendocrine signaling axes rather than intracellular enzymatic inhibition.

Researchers frequently evaluate these distinct pathways in comparative or co-treatment in vitro models to map intersecting networks governing energy expenditure, cellular stress responses, and age-related metabolic decline.

Designing Preclinical Protocols for Fat-Metabolism Research

When designing in vitro or animal model protocols focused on lipid turnover and metabolic rate, establishing consistent dosing parameters is essential. In rodent models, 5-Amino-1MQ is commonly investigated for its capacity to prevent diet-induced obesity without altering baseline food intake.

In vitro adipocyte differentiation assays typically utilize micromolar concentrations (e.g., 1 µM to 10 µM) to measure reductions in intracellular lipid droplet accumulation, downregulation of lipogenic genes, and upregulated oxygen consumption rates (OCR). Researchers utilizing Seahorse XF analyzers monitor real-time mitochondrial respiration to quantify changes in spare respiratory capacity following 5-Amino-1MQ exposure.

All experimental parameters must be calibrated based on precise stock concentration calculations. Reviewing comprehensive literature through the PX1 research database can help investigators baseline their experimental concentrations against published peer-reviewed data.

Institutional Procurement, Logistics, and Compliance

PX1 Research operates as a dedicated USA-based supplier of high-purity research compounds, servicing university laboratories, pharmaceutical research units, and independent private research organizations. All orders ship directly from domestic facilities located in California and Arizona, eliminating international customs delays and cold-chain exposure.

Orders placed Monday through Friday before cut-off times qualify for same-day dispatch, packaged in temperature-shielded insulation to preserve product integrity during transit. Institutional buyers requiring regular volume shipments or dedicated lot reservation can establish bulk lab accounts for streamlined procurement and scheduled delivery routes.

PX1 Research strictly enforces compliance with Federal and State regulations regarding laboratory chemicals. 5-Amino-1MQ is supplied exclusively for in vitro diagnostic, analytical, and preclinical laboratory research. It is not licensed, labeled, or intended for medical, therapeutic, diagnostic, or human dietary use.